‘Watch and Wait’ Feasible for Some Rectal Cancer Patients
Broader Genetic Testing Could ID More Heritable Cancers
Universal genetic testing catches genetic mutations not detected in guideline-based testing
New Cancer Drug Approvals Linked to Drop in Mortality
New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.
Medicare Outpatient Premium to Rise
Monthly premium for outpatient care will rise by $3.90 next year
Considerable Decreases Seen in Health Care Use During COVID-19
Reductions reported in colonoscopies, mammograms, child vaccines, in-person office visits; telemedicine service use up in March, April 2020
Mortality Down for Cancer Patients With Medicaid Expansion
Mortality reduced for patients with newly diagnosed breast, colorectal, lung cancers, mediated by earlier stage of diagnosis
Restricting Symptoms at the End of Life Decreasing
Decreases seen for difficulty sleeping; chest pain or tightness; shortness of breath; cold or flu symptoms; and nausea, vomiting, or diarrhea
Delay in Cancer Treatment Linked to Increased Mortality
Association between delay and increased mortality significant for 13 of 17 indications
~65 Percent of Office-Based Doctors Can ID Patients in Need of Follow-Up
More primary care physicians and those with an EHR system have computerized capability to ID patients due for preventive, follow-up care
